These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel naphthalenic ligands with high affinity for the melatonin receptor. Yous S; Andrieux J; Howell HE; Morgan PJ; Renard P; Pfeiffer B; Lesieur D; Guardiola-Lemaitre B J Med Chem; 1992 Apr; 35(8):1484-6. PubMed ID: 1315395 [No Abstract] [Full Text] [Related]
3. N-bromoacetyl 5-methoxytryptamine: an irreversible melatonin ligand? Chong NW; Evans JE; Sugden D Biochem Biophys Res Commun; 1993 Jun; 193(3):1355-61. PubMed ID: 8391805 [TBL] [Abstract][Full Text] [Related]
4. Melatonin binding sites in the central nervous system. Stankov B; Fraschini F; Reiter RJ Brain Res Brain Res Rev; 1991; 16(3):245-56. PubMed ID: 1665096 [No Abstract] [Full Text] [Related]
5. Quantitative structure-activity relationships within a series of melatonin analogs and related indolealkylamines. Lewis DF; Arendt J; English J J Pharmacol Exp Ther; 1990 Jan; 252(1):370-3. PubMed ID: 2153808 [TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase and melatonin in the retina: regulation, function and mode of action. Skene DJ Biochem Soc Trans; 1992 May; 20(2):312-5. PubMed ID: 1327915 [No Abstract] [Full Text] [Related]
7. Melatonin in vertebrate retina: biosynthesis, receptors and functions. Zawilska JB Pol J Pharmacol Pharm; 1992; 44(6):627-54. PubMed ID: 1339071 [TBL] [Abstract][Full Text] [Related]
11. [New naphthalenic ligands of melatoninergic receptors]. Adam G; Guardiola-Lemaitre B; Yous S; Lesieur D; Morgan P; Howell HE; Andrieux J; Caignard DH; Pfeiffer B; Renard P J Pharm Belg; 1992; 47(4):374-80. PubMed ID: 1328595 [TBL] [Abstract][Full Text] [Related]
12. [Melatonin receptors in the nervous system]. Yuan H Sheng Li Ke Xue Jin Zhan; 1991 Apr; 22(2):121-6. PubMed ID: 1665578 [No Abstract] [Full Text] [Related]
13. The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye. Osborne NN; Chidlow G Exp Eye Res; 1994 Jul; 59(1):3-9. PubMed ID: 7835395 [TBL] [Abstract][Full Text] [Related]
14. Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper. Slominski A; Paus R; Bomirski A J R Soc Med; 1989 Sep; 82(9):539-41. PubMed ID: 2552111 [TBL] [Abstract][Full Text] [Related]
15. Melatonin facts: Melatonin lacks immuno-inflammation boosting capacities at the molecular and cellular levels. Boutin JA; Hamon de Almeida V; Coussay N; Legros C; Ferry G; Reybier K Biochimie; 2024 Jul; 222():195-202. PubMed ID: 38508513 [TBL] [Abstract][Full Text] [Related]
16. Functional receptors for neurotransmitters on astroglial cells. Murphy S; Pearce B Neuroscience; 1987 Aug; 22(2):381-94. PubMed ID: 2823172 [No Abstract] [Full Text] [Related]
17. Melatonin level and risk for type 2 diabetes--in reply. McMullan CJ; Schernhammer ES; Forman JP JAMA; 2013 Aug; 310(5):537. PubMed ID: 23925631 [No Abstract] [Full Text] [Related]
18. Endocrinology meets immunology: T lymphocytes as novel targets for melatonin. Hofbauer LC; Heufelder AE Eur J Endocrinol; 1996 Apr; 134(4):424-5. PubMed ID: 8640289 [No Abstract] [Full Text] [Related]